AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
Stock Snapshot
AbbVie(ABBV) stock is priced at $294.25, giving the company a market capitalization of 518.45B. It carries a P/E multiple of 50.14 and pays a dividend yield of 2.38%.
As of 2026-11-09, AbbVie(ABBV) stock has fluctuated between $289.62 and $295.64. The current price stands at $294.25, placing the stock +1.6% above today's low and -0.5% off the high.
The AbbVie(ABBV)'s current trading volume is 5.87M, compared to an average daily volume of 5.78M.
In the last year, AbbVie(ABBV) shares hit a 52-week high of $302.93 and a 52-week low of $190.75.
In the last year, AbbVie(ABBV) shares hit a 52-week high of $302.93 and a 52-week low of $190.75.
ABBV News
...
AbbVie (ABBV) said Sunday that patients taking GLP-1 weight-loss medications reported improved satisfaction with their facial appearance following cosmetic trea...
Investing Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027? A blockbuster blood thinner is about to lose $1.5 billion to $2 billion in sales,...
Analyst ratings
74%
of 31 ratingsMore ABBV News
Six household-name dividend payers hand you a steady paycheck, but one of them gets taxed far harder than the other five. Find out which holding belongs in a Ro...
AbbVie guidance boost and dividend move draw fresh investor focus AbbVie (ABBV) has just paired a higher full year outlook with a dividend increase and a run o...
Abbvie (ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is studying a new injectable combination for moderate to severe upper...
Abbvie (ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s NCT07649954 trial, titled “A Phase 1 Open-Label, Two-Period Study t...
AbbVie (NYSE: ABBV) and Brise Pharmaceuticals signed an exclusive global license to co develop next generation migraine therapies. Brise will advance preclinic...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.